GlassScriptPhysician profile
Nuruddin Jooma
NPI 1376713727
$29,498.32
in general payments reported to CMS, 2019-2025
79 companies · $12K in 2025
The $12K reported for 2025 was more than what 83% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $1,638 · 2021: $1,224 · 2022: $3,006 · 2023: $3,601 · 2024: $6,755 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,089 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,145 · Honoraria: $2,610 · Consulting Fee: $2,560 · Long Term Medical Supply Or Device Loan: $2,196 · Travel and Lodging: $362 · Education: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,089.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,145.00 |
| Honoraria | $2,610.00 |
| Consulting Fee | $2,560.00 |
| Long Term Medical Supply Or Device Loan | $2,196.36 |
| Travel and Lodging | $361.80 |
| Education | $361.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $5,440.65 | 2019-2025 | Vectibix, Lumakras |
| Novartis Pharmaceuticals Corporation | $3,416.36 | 2019-2025 | |
| Geron Corporation | $3,032.79 | 2025 | Imetelstat |
| Pharmaessentia USA Corporation | $2,745.42 | 2022-2025 | Besremi |
| Cti Biopharma Corp. | $1,341.64 | 2022 | |
| Celgene Corporation | $1,014.22 | 2020-2025 | Reblozyl, Pomalyst, Opdualag |
| Exelixis INC. | $997.22 | 2021-2025 | Cabometyx |
| Astrazeneca Pharmaceuticals LP | $994.46 | 2019-2025 | Lynparza, Imfinzi, Enhertu |
| Adaptive Biotechnologies Corporation | $923.33 | 2020-2025 | Clonoseq |
| Daiichi Sankyo INC. | $706.22 | 2020-2025 | Enhertu, Datroway |
| Merck Sharp & Dohme LLC | $654.54 | 2019-2025 | Keytruda, Lynparza |
| Pfizer INC. | $605.51 | 2019-2025 | |
| Incyte Corporation | $527.49 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Gilead Sciences, INC. | $509.30 | 2021-2025 | Trodelvy |
| Rigel Pharmaceuticals, INC. | $470.51 | 2021-2025 | Rezlidhia, Tavalisse, Tavalisse |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $468.96 | 2019-2025 | Darzalex, Tecvayli, Rybrevant |
| Seagen INC. | $447.96 | 2019-2023 | Padcev, Adcetris, Tukysa |
| Glaxosmithkline, LLC. | $351.14 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Lilly USA, LLC | $324.14 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Astellas Pharma US INC | $316.27 | 2019-2025 | Padcev, Vyloy, Xtandi |
| E.R. Squibb & Sons, L.L.C. | $278.80 | 2019-2025 | Opdivo |
| Genentech USA, INC. | $254.32 | 2019-2025 | Phesgo, Kadcyla, Perjeta |
| Genzyme Corporation | $235.62 | 2019-2024 | |
| Abbvie INC. | $222.97 | 2019-2025 | |
| Csl Behring | $219.12 | 2021-2025 | Idelvion, Afstyla |
| Eisai INC. | $197.92 | 2019-2024 | |
| Array Biopharma INC | $166.03 | 2024-2025 | Braftovi, Lorbrena, Mektovi |
| Stryker Corporation | $149.01 | 2024 | Spinejack |
| Takeda Pharmaceuticals U.S.A., INC. | $128.93 | 2021-2024 | Alunbrig, Iclusig, Fruzaqla |
| Taiho Oncology, INC. | $126.14 | 2024-2025 | |
| Astellas Pharma Global Development | $125.45 | 2023 | Padcev |
| Jazz Pharmaceuticals INC. | $124.36 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.22 | 2019-2023 | |
| Ipsen Biopharmaceuticals, INC | $103.89 | 2019-2025 | Somatuline Depot, Onivyde |
| Tersera Therapeutics LLC | $98.80 | 2019-2024 | Zoladex |
| Mirati Therapeutics, INC. | $98.28 | 2023-2024 | Krazati |
| Pharmacosmos Therapeutics INC. | $96.59 | 2024-2025 | Monoferric, Cosela |
| Puma Biotechnology, INC. | $88.49 | 2019-2024 | |
| Tempus Ai, INC | $83.59 | 2024 | Xt Cdx |
| Pharmacyclics LLC, An Abbvie Company | $79.89 | 2020-2022 | |
| Deciphera Pharmaceuticals INC. | $68.49 | 2021-2022 | |
| Beigene USA, INC. | $64.48 | 2021-2025 | Tevimbra |
| Adc Therapeutics America, INC. | $61.10 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $60.11 | 2022-2023 | Libtayo |
| Beone Medicines USA, INC. | $54.94 | 2025 | Brukinsa |
| Aveo Pharmaceuticals, INC. | $52.08 | 2022-2023 | Fotivda |
| Springworks Therapeutics, INC. | $50.62 | 2024 | Ogsiveo |
| Legend Biotech USA INC. | $49.60 | 2024-2025 | Carvykti |
| Aurobindo Pharma USA, INC. | $48.00 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $47.85 | 2023-2025 | Orgovyx |
| Janssen Pharmaceuticals, INC | $43.71 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.06 | 2020-2023 | Gilotrif |
| Tesaro, INC. | $36.74 | 2019 | |
| Dova Pharmaceuticals | $36.69 | 2019 | |
| Myriad Genetic Laboratories, INC. | $36.17 | 2024 | Myrisk |
| Coloplast Corp | $35.72 | 2021 | |
| Emd Serono, INC. | $26.12 | 2025 | |
| Stemline Therapeutics INC. | $24.35 | 2023 | Orserdu |
| Sobi, INC | $22.75 | 2024 | |
| Progenics Pharmaceuticals, INC. | $22.74 | 2023 | Pylarify |
| Morphosys, US INC. | $22.65 | 2023 | Monjuvi |
| Foundation Medicine, INC. | $21.71 | 2023 | |
| Blueprint Medicines Corporation | $21.70 | 2025 | Ayvakit |
| Sun Pharmaceutical Industries INC. | $20.93 | 2019 | |
| Tg Therapeutics, INC. | $19.28 | 2021 | |
| Heron Therapeutics, INC. | $17.88 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $17.73 | 2019 | |
| Myovant Sciences INC. | $17.23 | 2022 | |
| Agios Pharmaceuticals, INC. | $17.03 | 2022 | |
| Immunomedics, INC. | $16.44 | 2020 | |
| Kite Pharma, INC. | $16.33 | 2021 | |
| Immunogen, INC. | $16.32 | 2023 | Elahere |
| Azurity Pharmaceuticals, INC. | $16.29 | 2025 | Danziten |
| Karyopharm Therapeutics INC. | $15.83 | 2023 | Xpovio |
| Verity Pharmaceuticals INC. | $14.96 | 2023 | Trelstar |
| Kyowa Kirin, INC. | $14.89 | 2021 | |
| Novocure INC. | $14.17 | 2025 | Optune Lua (Novottf-200t) |
| Ge Healthcare | $13.84 | 2021 | |
| Acrotech Biopharma INC. | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nuruddin Jooma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.